Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
PfizerPFE |
-$160,000 | |
AstrazenecaAZN |
-$630,000 | |
Johnson & JohnsonJNJ |
-$470,000 | |
ModernaMRNA |
-$67,000 | |
AbbVieABBV |
-$210,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Rohit Khanna Democrat | Apr 12, 2024 | Sell | $1K - $15K |
John James | Nov 10, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Oct 13, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Sep 8, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Aug 11, 2023 | Sell | $1K - $15K |
Daniel S. Goldman Democrat | Jul 10, 2023 | Sell | $15K - $50K |
Rohit Khanna Democrat | May 12, 2023 | Buy | $1K - $15K |
Daniel S. Goldman Democrat | Feb 27, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Feb 10, 2023 | Buy | $15K - $50K |
Who is the latest politician to buy or sell Sanofi shares?
Rohit Khanna sold Sanofi shares most recently on April 12, 2024.
Which politician has bought the most SNY stock in the last two years?
Rohit Khanna has bought the most SNY stock in the last 2 years, with an estimated value of $49,000.
Which politician has sold the most SNY stock over the last two years?
Daniel S. Goldman has sold the most SNY stock in the last 2 years, with an estimated value of $41,000.
What is the total value of politicians trading SNY stock in the last 2 years?
The net value of trades by US politicians for Sanofi in the last 2 years is negative, amounting to -$8,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on Sanofi's market confidence?
Over the last 2 years, insider transactions for Sanofi have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.